{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Latest Videos

{{ currentStream.Name }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

More Video

Jan 13, 2021

Bausch Health says revenue for full year to outperform previous outlook

Paul MacDonald discusses Bausch Health

VIDEO SIGN OUT

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

LAVAL, Que. - Bausch Health Companies Inc. says it expects its revenue for 2020 to top its guidance for the year, following a strong finish.

The company says it expects its revenue to total more than US$2.2 billion for its fourth quarter.

It also says revenue for its full year is expected to beat its guidance for between US$7.8 billion and US$8 billion.

Bausch Health made the comments ahead of a presentation at an investor conference.

The company expects to release its full financial results for the fourth quarter and the full year next month.

Analysts on average had expected US$2.1 billion in revenue for the fourth quarter and US$7.9 billion for the full year, according to financial data firm Refinitiv.